
Sultolin SR8 mg
Square Pharmaceuticals PLC.
Salbutamol is a short-acting beta-2 adrenergic agonist (SABA) bronchodilator used for the relief and prevention of bronchospasm in reversible obstructive airway disease.
Salbutamol is a short-acting beta-2 adrenergic agonist (SABA) bronchodilator used for the relief and prevention of bronchospasm in reversible obstructive airway disease.
Salbutamol is a bronchodilator only; it does not treat underlying airway inflammation and is not a substitute for inhaled corticosteroids in persistent asthma.
| Indication | Dose |
|---|---|
| Relief of acute bronchospasm | 1-2 inhalations (100-200 mcg) repeated every 4-6 hours as needed; some patients may respond to 1 inhalation every 4 hours |
| Prevention of exercise-induced bronchospasm | 2 inhalations 15-30 minutes before exercise |
| Age group | Dose | Frequency |
|---|---|---|
| Adults and children ≥12 years | 2.5-5 mg diluted in normal saline | Up to 4 times daily, or as directed for acute exacerbations |
| Children <12 years | 2.5 mg (weight/age-based, under medical supervision) | Up to 4 times daily |
| Age group | Dose |
|---|---|
| Adults and children >12 years | 2-4 mg, 3-4 times daily (maximum single dose 8 mg where tolerated, under medical advice) |
| Children 6-12 years | 2 mg (5 mL syrup), 3-4 times daily |
| Children 2-6 years | 1-2 mg (2.5 mL syrup), 3-4 times daily |
For severe acute bronchospasm unresponsive to inhaled therapy, Salbutamol may be given as a slow intravenous injection or infusion (typically 3-20 micrograms/minute), diluted as directed, under continuous medical and cardiac monitoring.
Doses should always be individualized to the lowest effective amount. An increasing need for Salbutamol indicates deteriorating asthma/COPD control and requires prompt medical reassessment of the overall treatment plan (see Precautions and Warnings).
The most commonly reported side effects of Salbutamol are dose-related and include:
Less commonly, Salbutamol can cause hypokalemia (particularly with high or frequent doses), hyperglycemia, and peripheral vasodilation. Rarely, it can cause a life-threatening paradoxical bronchospasm or hypersensitivity reactions (see Precautions and Warnings and Contraindications). Seek prompt medical attention for chest pain, irregular heartbeat, or worsening breathing difficulty after use.
Salbutamol is contraindicated in patients with known hypersensitivity to salbutamol or any component of the formulation. Prior hypersensitivity reactions have included urticaria, angioedema, rash, bronchospasm, and anaphylaxis.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.